Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2019, Article ID 9205851, 12 pages
https://doi.org/10.1155/2019/9205851
Research Article

Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo

Wei Wang,1,2,3,4 Zhenhua Hu,2,3 Yu Huang,1,2,3 Huilin Zheng,2,3 Qiang Sun,1,2,3 Qifan Yang,1,2,3 Yuan Zhang,1,2,3 Linshi Zhang,1,2,3 and Weilin Wang1,2,3

1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, China
2Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, The First Affiliated Hospital, School of Medicine, Zhejiang University, China
3Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital, School of Medicine, Zhejiang University, China
4Department of Gastrointestinal Surgery, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing 312000, Zhejiang, China

Correspondence should be addressed to Weilin Wang; nc.ude.ujz@maw

Received 1 November 2018; Accepted 27 February 2019; Published 25 March 2019

Academic Editor: Giandomenico Roviello

Copyright © 2019 Wei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Wei Wang, Zhenhua Hu, Yu Huang, et al., “Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo,” BioMed Research International, vol. 2019, Article ID 9205851, 12 pages, 2019. https://doi.org/10.1155/2019/9205851.